Kannalife is a biopharmaceutical company focused on the research and development of cannabinoid therapeutics. It provides proprietary cannabidiol (CBD) and CBD-like molecules for patients suffering from neurodegenerative disorders, including chemotherapy-induced peripheral neuropathy (CIPN), hepatic encephalopathy (HE), mild traumatic brain injury (mTBI), and chronic traumatic encephalopathy (CTE).